Zhejiang Wolwo Bio-Pharmaceutical Balance Sheet Health
Financial Health criteria checks 5/6
Zhejiang Wolwo Bio-Pharmaceutical has a total shareholder equity of CN¥2.4B and total debt of CN¥49.2M, which brings its debt-to-equity ratio to 2.1%. Its total assets and total liabilities are CN¥2.6B and CN¥241.2M respectively. Zhejiang Wolwo Bio-Pharmaceutical's EBIT is CN¥315.0M making its interest coverage ratio -10.5. It has cash and short-term investments of CN¥1.3B.
Key information
2.1%
Debt to equity ratio
CN¥49.17m
Debt
Interest coverage ratio | -10.5x |
Cash | CN¥1.28b |
Equity | CN¥2.38b |
Total liabilities | CN¥241.17m |
Total assets | CN¥2.62b |
Financial Position Analysis
Short Term Liabilities: 300357's short term assets (CN¥1.6B) exceed its short term liabilities (CN¥161.9M).
Long Term Liabilities: 300357's short term assets (CN¥1.6B) exceed its long term liabilities (CN¥79.3M).
Debt to Equity History and Analysis
Debt Level: 300357 has more cash than its total debt.
Reducing Debt: 300357's debt to equity ratio has increased from 0% to 2.1% over the past 5 years.
Debt Coverage: 300357's debt is well covered by operating cash flow (695.4%).
Interest Coverage: 300357 earns more interest than it pays, so coverage of interest payments is not a concern.